Angiodynamics (ANGO) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Angiodynamics (ANGO) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.91 Bn | 175.30 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 127.79 Bn | 122.57 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 116.85 Bn | 108.03 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 104.37 Bn | 100.89 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 63.81 Bn | 63.27 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.19 Bn | 30.25 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 20.67 Bn | 20.18 Bn | 684.20 Mn | 13.85% |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn | -85.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -85.46% |
| Feb 28, 2026 | -80.16% |
| Nov 30, 2025 | 41.75% |
| Aug 31, 2025 | 15.89% |
| May 31, 2025 | 55.76% |
| Feb 28, 2025 | 97.69% |
| Nov 30, 2024 | 63.67% |
| Aug 31, 2024 | -127.34% |
| May 31, 2024 | 38.44% |
| Feb 29, 2024 | -1,843.63% |
| Nov 30, 2023 | -236.10% |
| Aug 31, 2023 | 448.06% |
| May 31, 2023 | -238.51% |
| Feb 28, 2023 | -89.29% |
| Nov 30, 2022 | -0.49% |
| Aug 31, 2022 | -83.82% |
| May 31, 2022 | 68.36% |
| Feb 28, 2022 | -37.28% |
| Nov 30, 2021 | -92.03% |
| Aug 31, 2021 | -60.92% |